Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Politis, Marios ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN AGONIST; SEROTONIN RECEPTOR;

CELL SUSPENSION; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DYSKINESIA; GRAFT DYSFUNCTION; GRAFT FAILURE; HUMAN; INVOLUNTARY MOVEMENT; NERVE CELL; NERVE TRANSPLANTATION; NOTE; PARKINSON DISEASE; PATHOGENESIS; SEROTONINERGIC NERVE CELL; ANIMAL; BRAIN TRANSPLANTATION; EDITORIAL; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; DYSKINESIAS; HUMANS; PARKINSON DISEASE; SEROTONIN RECEPTOR AGONISTS; TREATMENT OUTCOME;

EID: 78649534741     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-80     Document Type: Note

References (15)

1. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211. 10.1016/S0197-4580(02)00065-9, 12498954.
2. Cotzias GC, Papavasiliou PS, Gellene R. Modification of Parkinsonism-chronic treatment with L-DOPA. N Engl J Med 1969, 280:337-345. 10.1056/NEJM196902132800701, 4178641.
3. Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1:382-393. 10.1602/neurorx.1.4.382, 534947, 15717042.
4. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719. 10.1056/NEJM200103083441002, 11236774.
5. Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002, 5:627-628.
6. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414. 10.1002/ana.10720, 12953276.
7. Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002, 52:628-634. 10.1002/ana.10359, 12402261.
8. Hagell P, Cenci MA. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Brain Res Bull 2005, 68:4-15. 10.1016/j.brainresbull.2004.10.013, 16324999.
9. Piccini P, Pavese N, Hagell P, Reimer J, Björklund A, Oertel WH, Quinn NP, Brooks DJ, Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986. 10.1093/brain/awh649, 16246865.
10. Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010, 2:38ra46.
11. Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport 1999, 10:631-634. 10.1097/00001756-199902250-00034, 10208602.
12. Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain 2007, 130:1819-1833. 10.1093/brain/awm082, 17452372.
13. De la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004, 127:2747-2754. 10.1093/brain/awh290, 15329355.
14. Politis M, Wu K, Loane C, Kiferle L, Molloy S, Bain P, Brooks DJ, Piccini P. Serotonergic involvement in L-DOPA-induced dyskinesia [abstract]. Mov Disord 2010, 25(Suppl 3):S658.
15. Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis 2010, 40:216-221. 10.1016/j.nbd.2010.05.028, 20594979.